EVALUATE LIMITEDActive
Key figures
Ratios
2024Balance sheet structure
Filed accounts2022–2024
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Turnover | 72,671,000 | 68,460,000 | 79,040,000 |
| Profit for the year | 13,369,000 | -19,251,000 | 18,776,000 |
| Cash at bank and in hand | 4,225,000 | 12,689,000 | 3,972,000 |
| Total assets | 100,306,000 | 81,527,000 | 102,759,000 |
| Total liabilities | — | — | — |
| Net assets / total equity | 42,885,000 | 16,584,000 | 35,360,000 |
| Average number of employees | 162 | 157 | 0 |
| Average pay (per year) | 117,531 | 93,796 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The principal activity of the Company is the provision of online information for the pharmaceutical industry.
As described in the company's latest filed accounts.
Summary: EVALUATE LIMITED
Company
EVALUATE LIMITED is a private limited company registered with Companies House under company number 05876322. It was incorporated on 14 Jul 2006. Its status is active. The registered office is in London (SE1). Its nature of business (SIC 2007) is data processing, hosting and related activities (63110), other information service activities n.e.c. (63990).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Turnover was £79,040,000. Profit for the year was £18,776,000. Net assets were £35,360,000, up 113.2% on the previous year. Cash at bank and in hand was £3,972,000. The company had an average of 0 employees. Figures are available for 3 financial years (2022–2024).
Control and charges
One person with significant control is registered. 2 of 5 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 13 May 2027.